Naviscon 250 mg+133.5 mg+80 mg (Chewable Tablet)
Medicine Details
Category | Details |
---|---|
Generic | Sodium alginate sodium bicarbonate calcium carbonate |
Company | Navana pharmaceuticals ltd |
Also available as |
Title
Naviscon 250 mg Chewable Tablet
Categories
- Medicine
- Antacids
- Gastric reflux relief
Description
Naviscon 250 mg Chewable Tablet is an antacid medication indicated for gastric reflux, heartburn, indigestion, and flatulence associated with gastric reflux. It contains a combination of two antacids (Calcium carbonate and Sodium bicarbonate) and an alginate (Sodium alginate) that work by neutralizing excess stomach acid and forming a protective barrier over the stomach contents to relieve pain and discomfort. The product is contraindicated in patients with known or suspected hypersensitivity to the active ingredients.
Brand
Naviscon
DosageForm
Chewable Tablet
Strength
250 mg
Indications
- Gastric reflux
- Heartburn
- Indigestion
- Flatulence associated with gastric reflux
- Heartburn of pregnancy
- Epigastric and retrosternal distress with gastric reflux
Pharmacology
- Combination of antacids and alginate
- Neutralizes excess stomach acid
- Forms protective barrier over stomach contents
- No systemic absorption
DosageAndAdministration
- OralSuspension:
- Adults and children over 12 years: 10-20 mL after meals and at bedtime, up to four times a day
- Children 6 to 12 years: 5-10 mL after meals and at bedtime, up to four times a day
- Children under 6 years: Not recommended
- Elderly: No dose modifications necessary
- ChewableTablet:
- Adults and children 12 years and over: Two to four tablets after meals and at bedtime, up to four times a day
- Children under 12 years: Tablets should be given only on medical advice
- SpecialPopulations:
- HepaticImpairment: No dose modification necessary
- RenalInsufficiency: Caution if highly restricted salt diet is necessary
Interaction
A time-interval of 2 hours should be considered between Naviscon intake and the administration of other medicinal products, especially Tetracyclines, Digoxine, Fluoroquinolone, Iron salt, Ketoconazole, Neuroleptics, Thyroid Hormones, Penicillamine, beta-blockers, Glucocorticoid, Chloroquine, Biphosphonates, and Estramustine
Contraindications
Known or suspected hypersensitivity to the active ingredients or excipients
SideEffects
- Constipation
- Flatulence
- Stomach cramps
- Belching
- Sensation of swelling with large doses
PregnancyAndLactation
- Pregnancy: Can be used if clinically needed
- Breastfeeding: No effects shown in breastfed newborns/infants
- Fertility: No negative effects on fertility or reproduction
PrecautionsAndWarnings
- High sodium and calcium content
- Care needed in hypercalcaemia and renal conditions
- Not recommended for children under 12 years without medical advice
- Avoid in phenylketonuria due to aspartame content
- Medical advice required if symptoms persist or treatment needed for more than 7 days continuously
- May mask symptoms of other serious medical conditions
- Not for use in impaired renal function/insufficiency or hypophosphatemia
OverdoseEffects
Symptomatic treatment for abdominal distension
TherapeuticClass
Antacids
StorageConditions
- Store below 30°C in a cool, dry place away from light
- Keep out of the reach of children
- Do not refrigerate or freeze
CommonlyAskedQuestions
- Ques1: What is Naviscon 250 mg Chew. Tablet?
- Ans1: Naviscon 250 mg Chew. Tablet is the combination of two antacids and an alginate commonly used to treat Gastric reflux, Heartburn, Indigestion, and Flatulence associated with gastric reflux
- Ques2: Is Naviscon 250 mg Chew. Tablet safe in pregnancy?
- Ans2: Naviscon 250 mg Chew. Tablet is safe to take during pregnancy and breastfeeding
Related Brands
- Gastisol Cool (500 mg+267 mg+160 mg)/10 ml (Oral Suspension) - biopharma-limited
- Gavipres (500 mg+267 mg+160 mg)/10 ml (Oral Suspension) - silva-pharmaceuticals-ltd
- Algicid Plus 250 mg+133.5 mg+80 mg (Chewable Tablet) - incepta-pharmaceuticals-ltd
- Gaviscon 250 mg+106 mg+187 mg (Chewable Tablet) - reckitt-benckiser-ltd
- Diodrox Plus (500 mg+267 mg+160 mg)/10 ml (Oral Suspension) - chemist-laboratories-ltd